Medlevensohn

What Medlevensohn does

Medlevensohn (legal name: MedLevensohn Comércio e Representações de Produtos Hospitalares LTDA) is a Brazilian privately held health products distributor founded in 2002 in Rio de Janeiro by José Marcos Szuster. The company operates five integrated business units — MedCare (hospital segment and government procurement/licitação, 300+ SKUs), MedFarma (pharmacy retail and pharmaceutical assistance, featuring the Diabetes Care line and On Call Plus II), MedHyper (cardiovascular monitoring using exclusive Microlife technology for physicians and health units), MedPOCT (point-of-care testing with 50+ rapid tests), and affiliated subsidiaries (Procsel for surgical products, Seroplast for plastic hospital products). Its portfolio spans diabetes care (blood glucose meters and strips, Smart/Smart 2.0 CGM sensors, HbA1c analyzers), cardiovascular (upper-arm and wrist BP monitors with AFIB detection, 24-hour MAPA devices, Mission lipid profile system), rapid diagnostics (50+ MedTeste tests covering infectious and chronic conditions), and respiratory/general care products (nebulizers, pulse oximeters, lancets, thermometers).

The company generates revenue through five primary streams: one-time product sales across its four therapeutic categories (diabetes, cardiovascular, rapid testing, respiratory/other) plus government procurement contracts won through competitive bidding. Pricing is not publicly disclosed; customers request quotes via the online "Orçamento Online" portal or transact through pharmacy retail chains. Go-to-market motions include enterprise field sales to hospitals and government entities, direct-to-pharmacy distribution through 10+ major chains, an e-commerce budget request system, and community outreach via the MedMóvel mobile health initiative. Exclusive distribution agreements with Acon Laboratories (since 2006) and Microlife, plus partnerships with MSD, AstraZeneca, and Servier, anchor product differentiation and specialist channel access.

MedLevensohn is headquartered in Rio de Janeiro with an office in São Paulo and a 6,500 m² distribution complex in Serra, Espírito Santo (inaugurated 2024 as an integrated R&D and national distribution center). The workforce reached 297 direct employees and 118 commercial sales representatives by 2019, supported by a nationwide commercial network spanning all of Brazil. Recent strategic moves include the 2024 acquisitions of Seroplast (with a R$120 million Espírito Santo investment) and a 50% stake in Procsel, the launch of the Smart 2.0 CGM system, and stated ambitions to double in size and explore an IPO. The company was named Brazilian Company of the Year 2024 and recognized in 2018 by Acon Laboratories as the world's largest distributor of On Call Plus glucose strips.

Name

Medlevensohn

Legal name

MedLevensohn Comércio e Representações de Produtos Hospitalares LTDA

Website

https://medlevensohn.com.br

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

101–250 employees

Short description

MedLevensohn is a Brazilian privately held health products distributor founded in 2002, operating five business units (MedCare, MedFarma, MedHyper, MedPOCT, MedTeste) that supply diabetes care, cardiovascular monitoring, rapid diagnostics, and respiratory products to pharmacies, hospitals, government entities, and consumers across Brazil.

Ownership category

akta.pro rank

Product category

Medical Device Distribution

SIC

Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests) (CRADAMAK)

akta.pro secondary industry

Medication Inventory, Procurement & Supply Chain (Pharmacy) (HLACAKAI)

Keywords

• Medical device distribution
• Rapid diagnostic tests
• Glucose monitoring products
• Cardiovascular monitoring devices
• Hospital medical supplies

Headquarters

HQ city

Rio De Janeiro

HQ country

Brazil

HQ region

Latin America

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure, Others

Revenue model

1. Product Sales — Diabetes Care: Sale of blood glucose meters, test strips, insulin pen needles, CGM sensors and transmitters, hemoglobin A1c analyzers and kits, and related consumables. Revenue generated through pharmacy chains, hospitals, government procurement, and direct sales.
2. Product Sales — Cardiovascular: Sale of blood pressure monitors (arm and wrist), MAPA devices, lipid profile monitors, cholesterol test strips, and cardiovascular product kits (e.g., Hyperchair + BP monitor bundles).
3. Product Sales — Rapid Testing: Sale of rapid test kits across 50+ disease categories including COVID-19, dengue, HIV, hepatitis, pregnancy, and others, sold to pharmacies, hospitals, clinical labs, and medical offices. Over 20 tests available for pharmacy use under RDC 786/23.
4. Product Sales — Respiratory & Other: Sale of respiratory products including nebulizers, pulse oximeters, nebulization cups, nasal aspiration accessories, as well as general care products such as safety lancets, surgical blades, pneumatic mattresses, and digital thermometers.
5. Public Procurement (Licitação): Government contracts through competitive bidding processes, supplying hospitals, municipal health departments, and public health systems across Brazil with medical supplies and diagnostic products.

Go-to-market motion3 records

Distribution channels6 records

Marketing channels8 records

Core offering

Medlevensohn distributes and supplies a portfolio of diagnostic and monitoring medical devices across Brazil, including blood glucose meters and strips, continuous glucose monitoring systems, automated blood pressure monitors, 24-hour ambulatory blood pressure (MAPA) devices, lipid profile analyzers, and over 50 rapid diagnostic tests covering infectious diseases, chronic conditions, and general health. The company sells through pharmacy retail chains, hospitals, public health system procurement (licitação), physician networks, and direct consumer channels, organized across four business platforms (MedCare, MedFarma, MedHyper, MedPOCT).

Product overview

MedLevensohn is a Brazilian health company with over 20 years of market experience offering a diversified portfolio of health products and services focused on prevention and care. The company operates through multiple business platforms: MedCare (hospital and government procurement), MedFarma (pharmacy), MedHyper (cardiovascular/blood pressure), MedPOCT (point-of-care testing). The product portfolio centers around Diabetes Care products including On Call Plus II glucose meters and Smart MedLevensohn/Smart 2.0 continuous glucose monitoring systems, a comprehensive line of over 43 MedTeste rapid diagnostic tests for conditions including COVID-19, dengue, HIV, hepatitis, and others, Microlife blood pressure monitors including AFIB technology devices and MAPA systems, Mission lipid profile monitoring products, respiratory products including nebulizers and pulse oximeters, and general care products including lancets, thermometers, and wound care items.

Differentiator

Problem solved

Functional benefit

Brands

• MedCare: Main business unit focused on hospital segment and public procurement (licitação), serving hundreds of public agencies, prefectures, and hospitals with more than 300 SKUs.
• MedFarma
• MedHyper
• MedPOCT
• MedTeste
• MedBem
• MedSocial
• MedMóvel
• Mission
• Smart
• On Call Plus
• Lumiratek C
• Glicolev Club

Products and services

• On Call Plus II Blood Glucose Meter (Monitor de Glicemia) Blood glucose monitoring system using GDH-FAD technology with No Code System for safer and more efficient glycemic monitoring, fully compliant with ISO 15197. Distributed exclusively in Brazil through the partnership with Acon Laboratories for use by consumers and healthcare professionals.
• On Call Plus II Blood Glucose Test Strips (Tiras para Teste de Glicemia) Consumable blood glucose test strips for the On Call Plus II meter, available in bottle or individualized packaging for daily glycemic monitoring by diabetes patients and clinical users.
• Smart MedLevensohn Continuous Glucose Monitoring System (CGM) Continuous glucose monitoring system with a subcutaneous sensor that measures glucose levels in interstitial fluid and transmits readings to an app, providing real-time glucose data for diabetes patients.
• Smart 2.0 Medlevensohn CGM Sensor Next-generation continuous glucose monitoring sensor with automatic glucose measurements every minute and 15 days of continuous use, noted as the smallest and most compact CGM sensor in Brazil.
• Hemoglobina Glicada Analyzer (HbA1c Analyzer) Analyzer device for measuring glycated hemoglobin (HbA1c) to assess long-term glycemic control in diabetes patients, used in clinical settings.
• Microlife Automatic Upper Arm Blood Pressure Monitor AFIB BPA200 Automatic upper arm blood pressure monitor with Microlife AFIB technology for atrial fibrillation detection during routine blood pressure measurement, used by patients at home and by clinicians.
• Microlife MAPA WatchBP 03 AFIB (24-Hour Ambulatory Blood Pressure Monitor) 24-hour ambulatory blood pressure monitoring (ABPM/MAPA) device with AFIB atrial fibrillation detection technology, supporting cardiovascular disease management from routine to sleep periods by physicians and clinical practices.
• Mission Complete Lipid Profile Monitor Point-of-care device for measuring complete lipid profile including total cholesterol, HDL, LDL, and triglycerides for cardiovascular risk assessment, used by clinical practices and pharmacies.
• MedTeste Rapid Diagnostic Test Line Portfolio of rapid diagnostic tests covering over 50 conditions including COVID-19, dengue, HIV, hepatitis, influenza, pregnancy, and others, using primary biological matrices without equipment processing. Sold to clinical labs, hospitals, pharmacies, and medical offices; 22+ tests can be performed in pharmacies under RDC 786/23.
• MedCare Business Unit (Hospital and Government Procurement Platform) Business unit focused on hospital segment and public procurement (licitação), serving hundreds of public agencies, municipalities, and hospitals across Brazil with a portfolio of over 300 SKUs of hospital consumables and diagnostic products.
• MedFarma Business Unit (Pharmacy and Pharmaceutical Assistance Platform) Business unit focused on pharmacy retail and pharmaceutical assistance consulting rooms, with the Diabetes Care line including On Call Plus II and the MedTeste rapid test portfolio available to pharmacies following RDC 786/23.
• MedHyper Business Unit (Cardiovascular and Physician Platform) Business unit focused on blood pressure control and cardiovascular disease monitoring, distributing Microlife technology including AFIB monitors and MAPA ambulatory devices to physicians and health units, with telemedicine integration.
• MedPOCT Business Unit (Point-of-Care Testing Platform) Business unit focused on Point-of-Care Testing (POCT), offering over 50 rapid diagnostic tests for clinical analysis labs, hospitals, pharmacies, and medical offices.
• MedLevensohn ML01 Portable Nebulizer (Nebulizador Portatil) Portable nebulizer device for respiratory therapy delivery in home and clinical settings.
• MedLevensohn ML02 Pulse Oximeter (Oximetro de Pulso) Pulse oximeter for non-invasive measurement of blood oxygen saturation (SpO2) and pulse rate, used at home and in clinical practice.

Quantifiable outcome

• Over 90% positive customer satisfaction ratings reported in June
• +3 more outcomes

Named customers13 records

Segments6 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Eleven partnerships are on record, tiered core, minor and flagship.

• ProcselcoreStrategic or Co-development Partner · 1 January 2025MedLevensohn acquired 50% of Procsel, a company specializing in surgical products. This acquisition extends MedLevensohn's portfolio into surgical supplies and strengthens its position in the broader health market.
• Antena 1minorGTM or Marketing Partner · 1 January 2025Community partnership with Antena 1 radio station for the MedMóvil community health event series. Joint outreach initiative bringing free health screenings to community locations (e.g., Parque Burle Marx events in São Paulo).
• 11:21 AgencyminorGTM or Marketing Partner · 1 January 2025Creative and marketing agency partnership for the launch campaign of the Smart glucometer product line. Agency resumed partnership with MedLevensohn for brand communication and campaign development.
• ServiercoreGTM or Marketing Partner · 1 January 2024Partnership with French pharmaceutical company Servier, initiated in 2024, for promotion of On Call Plus II and Microlife blood pressure monitors to endocrinologists and cardiologists. Focus on facilitating continuous glucose monitoring for patients.
• SeroplastcoreStrategic or Co-development Partner · 1 January 2024Acquisition of Seroplast, a manufacturer/supplier in the health products space. MedLevensohn announced a R$120 million investment plan in Espírito Santo associated with this acquisition, expanding manufacturing and operational capacity.
• SINCOFARMAminorStrategic or Co-development Partner · 1 January 2023MedLevensohn co-organized with SINCOFARMA (pharmacy industry association) a presentation on RDC 786/23 regulations for pharmacy rapid testing, supporting industry education and regulatory adoption.
• MSD (Merck Sharp & Dohme)flagshipGTM or Marketing Partner · 1 January 2018Promotional partnership with MSD for the Mission Cholesterol System and Lumiratek C Hemoglobin Monitor targeting cardiologists. Joint marketing and promotional activities to drive adoption among cardiovascular specialists.
• AstraZeneca BrasilflagshipGTM or Marketing Partner · 1 January 2018Partnership with AstraZeneca Brasil for promotion of the Lumiratek C Hemoglobin Monitor to healthcare professionals. Joint GTM activities with the pharmaceutical company targeting endocrinology and cardiology specialties.
• Multiple International Partners (14th international partner)coreTechnology or Integration · 1 January 2014By 2014, MedLevensohn had established partnerships with 14 international partners, consolidating an extensive and differentiated product portfolio spanning glucose monitoring, cardiovascular, and rapid testing categories.
• WalmartminorChannel Partner/ Reseller/ Distributor · 1 January 2008Distribution partnership with Walmart beginning in 2008, expanding retail distribution channels for MedLevensohn products.
• Acon Laboratories, Inc.coreTechnology or Integration · 1 January 2006Exclusive partnership established in 2006 for distribution of On Call Plus glucose test strips in Brazil. Distribution expanded nationwide by 2007. At the 2018 International Convention in Orlando, Acon Laboratories honored MedLevensohn as the largest On Call Plus distributor in the world. The partnership was later extended to include On Call Plus II (ISO 15197 compliant, launched 2017) and On Call Extra product lines.

Scale indicators10 records

Recent moves8 records

Expansion highlights7 records

Regional players

• Eurofarma: Major Brazilian pharmaceutical company with hospital, prescription, and consumer health lines distributed nationally — adjacent competitor in Brazilian healthcare distribution and public procurement.
• EMS Pharma: Largest Brazilian pharmaceutical company with consumer health and diagnostics products distributed through pharmacy chains — operates in adjacent health product categories within the same Brazilian market.

Broad incumbents

• Bayer Brazil (Consumer Health): Major consumer health player in Brazil with blood pressure monitors and cardiovascular products sold through pharmacy chains — competing in MedLevensohn's MedHyper and MedFarma channels.
• Sanofi Brazil: Global diabetes franchise (insulin, monitoring) with strong Brazilian presence and pharmacy distribution — overlaps with MedLevensohn's diabetes care and pharmacy channel strategy.
• Roche Diagnostics Brazil: Global diagnostics leader with direct presence in Brazil across glucose monitoring, rapid testing, and hospital diagnostics — a broad incumbent competing in multiple of MedLevensohn's product categories.
• Abbott Diabetes Care Brazil: Global leader in continuous glucose monitoring (FreeStyle Libre) with established Brazilian operations directly competing with MedLevensohn's Smart CGM franchise in the diabetes monitoring category.
• Medtronic Brazil: Global medical device leader with diabetes and cardiovascular portfolios distributed in Brazil — overlaps with MedLevensohn's MedHyper cardiovascular monitoring and diabetes care product lines.
• Omron Healthcare: Global leader in home blood pressure monitoring with established Brazilian distribution — competes with MedLevensohn's Microlife-based MedHyper cardiovascular product portfolio.

Direct peers

• Halex Istar: Brazilian medical-hospital products manufacturer and distributor with national reach across hospital supplies, comparable to MedLevensohn's multi-channel hospital procurement and distribution operations.
• Lifemed: Brazilian medical devices and hospital supplies distributor serving hospitals, clinics, and government procurement channels — directly comparable to MedLevensohn's MedCare unit business model and customer base in Brazil.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@Medlevensohn
• Facebookfacebook.com/medlevensohn
• LinkedInlinkedin.com/company/medlevensohn
• Instagraminstagram.com/medlevensohn
• Xx.com/medlevensohn

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medlevensohn